9th Mar 2021 14:34
Genedrive PLC - Manchester, England-based molecular diagnostics firm - Enters agreement with Mountain Horse Solutions, a military contracting specialist to US federal, state and local government customers for distribution of its military pathogen detection assays in the US. Notes the Genedrive BioPlex range of products was developed to the product specification of the US Department of Defense, who helped fund the range. Says it believes establishing new, local representation in the US will help drive broader product uptake.
"The agreement allows the supply of our BioPlex pathogen detection assays through Mountain Horse, a military contracting specialist who has a number of existing framework contracts with target clients such as the US DoD. We believe that they have both the industry sector knowledge and existing commercial arrangements to increase the exposure of our products and gain new customer opportunities within the various branches and departments of the DoD and US government," says Chief Executive David Budd.
Current stock price: 136.64 pence
Year-to-date change: up 2.4%
By Zoe Wickens; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Genedrive